209 related articles for article (PubMed ID: 36818932)
1. SIALORRHEA AND XEROSTOMIA IN PARKINSON'S DISEASE PATIENTS.
Špiljak B; Lisak M; Pašić H; Trkanjec Z; Lovrenčić Huzjan A; Bašić Kes V
Acta Clin Croat; 2022 Aug; 61(2):320-326. PubMed ID: 36818932
[TBL] [Abstract][Full Text] [Related]
2. Salivation in Parkinson's disease: A scoping review.
Verhoeff MC; Koutris M; Vries R; Berendse HW; Dijk KDV; Lobbezoo F
Gerodontology; 2023 Mar; 40(1):26-38. PubMed ID: 35246869
[TBL] [Abstract][Full Text] [Related]
3. Saliva changes in Parkinson's disease patients after injection of Botulinum neurotoxin type A.
Tiigimäe-Saar J; Tamme T; Rosenthal M; Kadastik-Eerme L; Taba P
Neurol Sci; 2018 May; 39(5):871-877. PubMed ID: 29460161
[TBL] [Abstract][Full Text] [Related]
4. Sialorrhea in Parkinson's disease: a review.
Chou KL; Evatt M; Hinson V; Kompoliti K
Mov Disord; 2007 Dec; 22(16):2306-13. PubMed ID: 17659637
[TBL] [Abstract][Full Text] [Related]
5. Glycopyrrolate Improves Disability From Sialorrhea in Parkinson's Disease: A 12-Week Controlled Trial.
Mestre TA; Freitas E; Basndwah A; Lopez MR; de Oliveira LM; Al-Shorafat DM; Zhang T; Lui JP; Grimes D; Fox SH
Mov Disord; 2020 Dec; 35(12):2319-2323. PubMed ID: 32657457
[TBL] [Abstract][Full Text] [Related]
6. Design and development of a novel supportive care product for the treatment of sialorrhea in Parkinson's disease.
Farber NM; Perez-Lloret S; Gamzu ER
Curr Top Med Chem; 2015; 15(10):939-54. PubMed ID: 25832720
[TBL] [Abstract][Full Text] [Related]
7. A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI.
Wolff A; Joshi RK; Ekström J; Aframian D; Pedersen AM; Proctor G; Narayana N; Villa A; Sia YW; Aliko A; McGowan R; Kerr AR; Jensen SB; Vissink A; Dawes C
Drugs R D; 2017 Mar; 17(1):1-28. PubMed ID: 27853957
[TBL] [Abstract][Full Text] [Related]
8. Sialorrhea in Parkinson's Disease.
Isaacson J; Patel S; Torres-Yaghi Y; Pagán F
Toxins (Basel); 2020 Oct; 12(11):. PubMed ID: 33142833
[TBL] [Abstract][Full Text] [Related]
9. Drooling in Parkinson's disease: a review.
Srivanitchapoom P; Pandey S; Hallett M
Parkinsonism Relat Disord; 2014 Nov; 20(11):1109-18. PubMed ID: 25200111
[TBL] [Abstract][Full Text] [Related]
10. Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease.
Evatt ML; Chaudhuri KR; Chou KL; Cubo E; Hinson V; Kompoliti K; Yang C; Poewe W; Rascol O; Sampaio C; Stebbins GT; Goetz CG
Mov Disord; 2009 Apr; 24(5):635-46. PubMed ID: 19205066
[TBL] [Abstract][Full Text] [Related]
11. Circadian rhythms and influencing factors of xerostomia among Parkinson's disease patients.
Barbe AG; Ludwar L; Scharfenberg I; Hellmich M; Dano R; Barbe MT; Noack MJ
Oral Dis; 2019 Jan; 25(1):282-289. PubMed ID: 30028552
[TBL] [Abstract][Full Text] [Related]
12. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease.
Ondo WG; Hunter C; Moore W
Neurology; 2004 Jan; 62(1):37-40. PubMed ID: 14718694
[TBL] [Abstract][Full Text] [Related]
13. Sialorrhea in patients with Parkinson's disease: safety and administration of botulinum neurotoxin.
Egevad G; Petkova VY; Vilholm OJ
J Parkinsons Dis; 2014; 4(3):321-6. PubMed ID: 24919823
[TBL] [Abstract][Full Text] [Related]
14. BoNT clinical trial update: Sialorrhea.
Tamadonfar ET; Lew MF
Toxicon; 2023 Apr; 226():107087. PubMed ID: 36931440
[TBL] [Abstract][Full Text] [Related]
15. Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease.
Perez Lloret S; Pirán Arce G; Rossi M; Caivano Nemet ML; Salsamendi P; Merello M
Mov Disord; 2007 Jan; 22(1):107-11. PubMed ID: 17089393
[TBL] [Abstract][Full Text] [Related]
16. Drooling rating scales in Parkinson's disease: A systematic review.
Nascimento D; Carmona J; Mestre T; Ferreira JJ; Guimarães I
Parkinsonism Relat Disord; 2021 Oct; 91():173-180. PubMed ID: 34583888
[TBL] [Abstract][Full Text] [Related]
17. State-of-the-art pharmacotherapy for autonomic dysfunction in Parkinson's disease.
Quarracino C; Otero-Losada M; Capani F; Pérez-Lloret S
Expert Opin Pharmacother; 2020 Mar; 21(4):445-457. PubMed ID: 31957505
[No Abstract] [Full Text] [Related]
18. Dihydroergotoxine mesylate for the treatment of sialorrhea in Parkinson's disease.
Cheng YQ; Ge NN; Zhu HH; Sha ZT; Jiang T; Zhang YD; Tian YY
Parkinsonism Relat Disord; 2019 Jan; 58():70-73. PubMed ID: 30177490
[TBL] [Abstract][Full Text] [Related]
19. Excessive buccal saliva in patients with Parkinson's disease of the French COPARK cohort.
Rascol O; Negre-Pages L; Damier P; Delval A; Derkinderen P; Destée A; Fabbri M; Meissner WG; Rachdi A; Tison F; Perez-Lloret S;
J Neural Transm (Vienna); 2020 Dec; 127(12):1607-1617. PubMed ID: 32880023
[TBL] [Abstract][Full Text] [Related]
20. Sialorrhea: a review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease.
Boyce HW; Bakheet MR
J Clin Gastroenterol; 2005 Feb; 39(2):89-97. PubMed ID: 15681902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
